Answers are grounded in this paper and cite their sources.
Background: Idiopathic pulmonary fibrosis (IPF) is one of the interstitial lung diseases. To date, most drug trials for the treatment of IPF have yielded disappointing results. Recently, selenium nano-particles (SeNP) have received attention for potential use in treatments, due in part to their established abilities to exert size-dependent anti-oxidant/-inflammatory effects.
No takes yet. Share an insight, caveat, or question.
Farinaz Nasirinezhad (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: